Skip to main content increases safety of coronavirus vaccinations

| News increases safety of coronavirus vaccinations


The Basel-based startup has developed an app that aims to increase the safety and efficacy of COVID-19 vaccinations. The company has agreed a partnership with the German umbrella organization of specialized physicians (SpiFa).

As detailed in a press release, the Basel startup AG is the new innovation and technology partner of SpiFa (Spitzenverband Fachärzte Deutschland), the German umbrella organization of specialized physicians. SpiFa has recommended to its members – some 160,000 doctors – that they should use an app developed by after COVID-19 vaccinations.

The app can be used to collect data which is then anonymously forwarded on to the Paul Ehrlich Institute, otherwise known as the Federal Institute for Vaccines and Biomedicines in Germany. A broad database should also allow processes to be optimized, which will result in improved safety and efficacy for COVID-19 vaccinations.

“We see huge potential for our app in Switzerland”, comments Yves Nordmann, co-founder and Chief Medical Officer (CMO) of, in the press release. Founded in 2017, AG develops solutions to improve communications between doctor and patient. “The focus is on healthcare provision that prioritizes quality over quantity with the help of digital therapy solutions”, explains co-founder and CEO Ulrich Mühlner, who was also formerly a Senior Manager at Novartis.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.